Retour
Fourchette du Jour
73,18 €
74,63 €
Fourchette 52 Semaines
60,56 €
89,29 €
Volume
1 044 019
Moyenne 50J / 200J
77,69 €
/
72,09 €
Clôture Précédente
74,46 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 21,9 | 0,3 |
| P/B | 2,7 | 2,9 |
| ROE % | 12,0 | 3,7 |
| Net Margin % | 3,0 | 3,8 |
| Rev Growth 5Y % | 1,5 | 10,0 |
| D/E | 1,1 | 0,2 |
Objectif de Cours des Analystes
Hold
90,17 €
+21.8%
Low: 81,00 €
High: 100,00 €
P/E Prévisionnel
14,1
BPA Prévisionnel
5,29 €
Croissance BPA (est.)
+0,0%
CA Est.
14 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
6,80 €
6,75 € – 6,85 €
|
15 B | 1 |
| FY2028 |
6,42 €
5,75 € – 6,93 €
|
15 B | 5 |
| FY2027 |
5,84 €
5,71 € – 6,05 €
|
14 B | 10 |
Points Clés
Revenue grew 1,54% annually over 5 years — modest growth
ROE of 11,99% — decent returns on equity
Generating 573,00M in free cash flow
Cash machine — converts 143,97% of earnings into free cash flow
Capital efficient — spends only 1,05% of revenue on capex
Croissance
Revenue Growth (5Y)
1,54%
Revenue (1Y)4,03%
Earnings (1Y)2,05%
FCF Growth (3Y)27,41%
Qualité
Return on Equity
11,99%
ROIC8,20%
Net Margin3,02%
Op. Margin5,75%
Sécurité
Debt / Equity
1,14
Current Ratio1,38
Interest Coverage5,05
Valorisation
P/E Ratio
21,89
P/B Ratio2,69
EV/EBITDA16,15
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,03% | Revenue Growth (3Y) | 3,37% |
| Earnings Growth (1Y) | 2,05% | Earnings Growth (3Y) | -2,19% |
| Revenue Growth (5Y) | 1,54% | Earnings Growth (5Y) | -10,63% |
| Profitability | |||
| Revenue (TTM) | 13,18B | Net Income (TTM) | 398,00M |
| ROE | 11,99% | ROA | 3,55% |
| Gross Margin | 29,14% | Operating Margin | 5,75% |
| Net Margin | 3,02% | Free Cash Flow (TTM) | 573,00M |
| ROIC | 8,20% | FCF Growth (3Y) | 27,41% |
| Safety | |||
| Debt / Equity | 1,14 | Current Ratio | 1,38 |
| Interest Coverage | 5,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 21,89 | P/B Ratio | 2,69 |
| P/S Ratio | 0,66 | PEG Ratio | 3,22 |
| EV/EBITDA | 16,15 | Dividend Yield | 0,00% |
| Market Cap | 8,71B | Enterprise Value | 12,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13,18B | 12,67B | 12,34B | 12,65B | 12,40B |
| Net Income | 398,00M | 390,00M | 416,00M | 538,00M | 623,91M |
| EPS (Diluted) | 3,27 | 3,05 | 3,16 | 3,91 | 4,45 |
| Gross Profit | 3,84B | 3,77B | 3,65B | 3,65B | 3,67B |
| Operating Income | 758,00M | 729,00M | 714,00M | 938,00M | 854,81M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11,22B | 10,22B | 10,57B | 8,61B | 8,48B |
| Total Liabilities | 6,42B | 5,38B | 5,42B | 3,94B | 3,81B |
| Shareholders' Equity | 3,25B | 3,39B | 3,66B | 3,45B | 3,43B |
| Total Debt | 3,69B | 2,87B | 2,74B | 1,50B | 1,22B |
| Cash & Equivalents | 156,00M | 122,00M | 171,00M | 117,00M | 118,00M |
| Current Assets | 4,46B | 3,98B | 4,49B | 3,99B | 3,84B |
| Current Liabilities | 3,23B | 2,80B | 2,68B | 2,22B | 2,31B |